CrisprBits enters into an exciting strategic partnership with MolBio diagnostics, a global pioneer in point of care testing. The collaboration will aim to make the highly accurate nucleic acid diagnostics tests pervasive, cost friendly and instrument-light using CrisprBits’ proprietary PathCrisp platform. MolBio will leverage both its technical and vast marketing capabilities to bring a wide number of these tests to the masses.